Effects of long-term antihypertensive therapy on physical fitness of men with mild hypertension.

This study was conducted to investigate the effects of long-term administration of a calcium-channel antagonist (nifedipine) and a beta-blocker (acebutolol) on physical fitness in men with mild hypertension. All subjects underwent symptom-limited treadmill stress testing and routine echocardiographic studies. Twenty-two subjects who had either a causal diastolic blood pressure of more than 105 mmHg or a left ventricular mass index (LVMI) of 125 g/m2 or more during follow-up were assigned to receive medical therapy. The other 31 men who did not meet either criterion were continuously followed-up without medication. Among the 22 treated men, the age-adjusted treadmill time (normalized treadmill time, TMTn) significantly decreased before the initiation of medication, while 31 untreated men showed no change in TMTn throughout the study. The 22 treated subjects were subsequently divided into two groups; 13 were given nifedipine and 9 were given acebutolol. All treated subjects were followed-up for more than 3 years. After treatment, the two groups showed similar reductions in blood pressure and LVMI, but a different outcome for TMTn: TMTn increased from 104 +/- 8% to 115 +/- 16% in subjects given nifedipine (p < 0.05) and decreased from 106 +/- 12% to 99 +/- 10% (p < 0.01) in those given acebutolol. Thus, the physical fitness of subjects who required medication significantly deteriorated without medication; their physical fitness improved after treatment with a calcium-channel antagonist and deteriorated after treatment with a beta-blocker.

[1]  N. Doba,et al.  Prospective studies on left ventricular geometric patterns and exercise tolerance in unmedicated men with borderline and mild hypertension , 1996, Journal of hypertension.

[2]  R S Paffenbarger,et al.  Exercise intensity and longevity in men. The Harvard Alumni Health Study. , 1995, JAMA.

[3]  R S Paffenbarger,et al.  Changes in physical fitness and all-cause mortality. A prospective study of healthy and unhealthy men. , 1995, JAMA.

[4]  K. Hiwada,et al.  Effects of Long‐Term Treatment with Sustained‐Release Nicardipine on Left Ventricular Hypertrophy and Function in Patients with Essential Hypertension , 1994, Journal of clinical pharmacology.

[5]  A. Cohen-Solal,et al.  Cardiopulmonary response during exercise of a beta 1-selective beta-blocker (atenolol) and a calcium-channel blocker (diltiazem) in untrained subjects with hypertension. , 1993, Journal of Cardiovascular Pharmacology.

[6]  J. Manson,et al.  The primary prevention of myocardial infarction. , 1992, The New England journal of medicine.

[7]  N. Doba,et al.  Prediction of Progression of Left Ventricular Hypertrophy in Mild Hypertension: 5-Year Observations without Pharmacological Intervention , 1992 .

[8]  I. Hjermann.  The Metabolic Cardiovascular Syndrome: Syndrome X, Reaven's Syndrome, Insulin Resistance Syndrome, Atherothrombogenic Syndrome , 1992, Journal of cardiovascular pharmacology.

[9]  A. Amery,et al.  Effect of antihypertensive medication on endurance exercise capacity in hypertensive sportsmen. , 1991, Journal of hypertension.

[10]  N. Gordon,et al.  Effect of beta-blockers on exercise physiology: implications for exercise training. , 1991, Medicine and science in sports and exercise.

[11]  R S Paffenbarger,et al.  Physical fitness and all-cause mortality. A prospective study of healthy men and women. , 1989, JAMA.

[12]  D. Miller,et al.  Nifedipine, but not propranolol, improves left ventricular systolic and diastolic function in patients with hypertension. , 1989, The American journal of cardiology.

[13]  N. Kaplan.  The Deadly Quartet: Upper-Body Obesity, Glucose Intolerance, Hypertriglyceridemia, and Hypertension , 1989 .

[14]  J. Staessen,et al.  Maximal aerobic power in essential hypertension. , 1988, Journal of hypertension.

[15]  I. Franz,et al.  Oxygen uptake and plasma catecholamines during submaximal and maximal exercise after long-term β-receptor blockade , 1985 .

[16]  R. Fagard.  Habitual Physical Activity, Training, and Blood Pressure in Normo- and Hypertension , 1985, International journal of sports medicine.

[17]  J S Janicki,et al.  Cardiopulmonary exercise testing for evaluation of chronic cardiac failure. , 1985, The American journal of cardiology.

[18]  W. Klein,et al.  Role of Calcium Antagonists in the Treatment of Essential Hypertension , 1983, Circulation research.

[19]  K. Hossack,et al.  Value of maximal exercise tests in risk assessment of primary coronary heart disease events in healthy men. Five years' experience of the Seattle heart watch study. , 1980, The American journal of cardiology.

[20]  N. Doba,et al.  [Functional evaluation of the oxygen transport system with multiphasic treadmill stress testing after Bruce's protocol: racial difference in cardiovascular response to exercise (author's transl)]. , 1980, Kokyu to junkan. Respiration & circulation.

[21]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[22]  N Reichek,et al.  Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method , 1977, Circulation.

[23]  R Gorlin,et al.  Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. , 1976, The American journal of cardiology.

[24]  D. Hosmer,et al.  Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease. , 1973, American heart journal.

[25]  R. Bruce,et al.  Longitudinal variations in maximal oxygen intake with age and activity. , 1972, Journal of applied physiology.

[26]  R. Bruce,et al.  Impaired Maximal Exercise Performance with Hypertensive Cardiovascular Disease , 1969, Circulation.

[27]  L. Katz,et al.  The Relation of Cardiac Effort to Myocardial Oxygen Consumption and Coronary Flow , 1958, Circulation research.